Half-year report · HY
3161.TEDINET S100X9JD
Period2025-05-01 → 2025-10-31
Filed2025-12-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.8bn | 2025-05-01 → 2025-10-31 | Cons. | Net sales |
| Revenue | ¥8.0bn | 2024-05-01 → 2025-04-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.7bn | 2024-05-01 → 2024-10-31 | Cons. | Net sales |
| Operating income | ¥12m | 2025-05-01 → 2025-10-31 | Cons. | Operating income |
| Operating income | ¥57m | 2024-05-01 → 2024-10-31 | Cons. | Operating income |
| Ordinary income | ¥21m | 2025-05-01 → 2025-10-31 | Cons. | Ordinary income |
| Ordinary income | ¥217m | 2024-05-01 → 2025-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥67m | 2024-05-01 → 2024-10-31 | Cons. | Ordinary income |
| Profit before tax | ¥20m | 2025-05-01 → 2025-10-31 | Cons. | Income before income taxes |
| Profit before tax | ¥87m | 2024-05-01 → 2024-10-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥5m | 2025-05-01 → 2025-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥199m | 2024-05-01 → 2025-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥66m | 2024-05-01 → 2024-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥5m | 2025-05-01 → 2025-10-31 | Cons. | Profit loss |
| Net income | ¥66m | 2024-05-01 → 2024-10-31 | Cons. | Profit loss |
| Total assets | ¥8.2bn | at 2025-10-31 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2025-04-30 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2024-10-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.6bn | at 2025-10-31 | Cons. | Liabilities |
| Total liabilities | ¥1.7bn | at 2025-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.7bn | at 2025-10-31 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2025-04-30 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2024-10-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2025-10-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2025-04-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2025-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2025-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2024-04-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥240m | 2025-05-01 → 2025-10-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥466m | 2024-05-01 → 2025-04-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥76m | 2024-05-01 → 2024-10-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥242m | 2025-05-01 → 2025-10-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥165m | 2024-05-01 → 2025-04-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥97m | 2024-05-01 → 2024-10-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥190m | 2025-05-01 → 2025-10-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥246m | 2024-05-01 → 2025-04-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥190m | 2024-05-01 → 2024-10-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥0.86 | 2025-05-01 → 2025-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.97 | 2024-05-01 → 2025-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.52 | 2024-05-01 → 2024-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.7% | at 2025-10-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.1% | at 2025-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.4% | at 2024-10-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-05-01 → 2025-10-31 | ¥132m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-05-01 → 2025-10-31 | ¥113m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-05-01 → 2025-10-31 | ¥20m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-05-01 → 2025-10-31 | −¥11m |
| Reconciling Itemsreconciling | revenue | 2025-05-01 → 2025-10-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-05-01 → 2025-10-31 | −¥23m |
| Reconciling Itemsreconciling | segment profit | 2025-05-01 → 2025-10-31 | −¥224m |
| Health Care Productsreportable segment | revenue | 2025-05-01 → 2025-10-31 | ¥154m |
| Health Care Productsreportable segment | revenue external | 2025-05-01 → 2025-10-31 | ¥154m |
| Health Care Productsreportable segment | revenue intersegment | 2025-05-01 → 2025-10-31 | ¥12,000 |
| Health Care Productsreportable segment | segment profit | 2025-05-01 → 2025-10-31 | −¥24m |
| Life Materialsreportable segment | revenue | 2025-05-01 → 2025-10-31 | ¥1.5bn |
| Life Materialsreportable segment | revenue external | 2025-05-01 → 2025-10-31 | ¥1.5bn |
| Life Materialsreportable segment | revenue intersegment | 2025-05-01 → 2025-10-31 | ¥3m |
| Life Materialsreportable segment | segment profit | 2025-05-01 → 2025-10-31 | ¥88m |
| Protective Clothing And Environmental Materialsreportable segment | revenue | 2025-05-01 → 2025-10-31 | ¥2.0bn |
| Protective Clothing And Environmental Materialsreportable segment | revenue external | 2025-05-01 → 2025-10-31 | ¥2.0bn |
| Protective Clothing And Environmental Materialsreportable segment | segment profit | 2025-05-01 → 2025-10-31 | ¥184m |
| —segment total | revenue | 2025-05-01 → 2025-10-31 | ¥3.7bn |
| —segment total | revenue external | 2025-05-01 → 2025-10-31 | ¥3.7bn |
| —segment total | revenue intersegment | 2025-05-01 → 2025-10-31 | ¥3m |
| —segment total | segment profit | 2025-05-01 → 2025-10-31 | ¥248m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-05-01 → 2025-10-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-05-01 → 2025-10-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-05-01 → 2025-10-31 | ¥23m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-05-01 → 2025-10-31 | ¥237m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-05-01 → 2024-10-31 | ¥175m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-05-01 → 2024-10-31 | ¥170m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-05-01 → 2024-10-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-05-01 → 2024-10-31 | −¥19m |
| Reconciling Itemsreconciling | revenue | 2024-05-01 → 2024-10-31 | −¥14m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-05-01 → 2024-10-31 | −¥14m |
| Reconciling Itemsreconciling | segment profit | 2024-05-01 → 2024-10-31 | −¥184m |
| Health Care Productsreportable segment | revenue | 2024-05-01 → 2024-10-31 | ¥92m |
| Health Care Productsreportable segment | revenue external | 2024-05-01 → 2024-10-31 | ¥92m |
| Health Care Productsreportable segment | segment profit | 2024-05-01 → 2024-10-31 | −¥12m |
| Life Materialsreportable segment | revenue | 2024-05-01 → 2024-10-31 | ¥1.5bn |
| Life Materialsreportable segment | revenue external | 2024-05-01 → 2024-10-31 | ¥1.5bn |
| Life Materialsreportable segment | revenue intersegment | 2024-05-01 → 2024-10-31 | ¥5m |
| Life Materialsreportable segment | segment profit | 2024-05-01 → 2024-10-31 | ¥97m |
| Protective Clothing And Environmental Materialsreportable segment | revenue | 2024-05-01 → 2024-10-31 | ¥2.0bn |
| Protective Clothing And Environmental Materialsreportable segment | revenue external | 2024-05-01 → 2024-10-31 | ¥2.0bn |
| Protective Clothing And Environmental Materialsreportable segment | revenue intersegment | 2024-05-01 → 2024-10-31 | ¥4m |
| Protective Clothing And Environmental Materialsreportable segment | segment profit | 2024-05-01 → 2024-10-31 | ¥175m |
| —segment total | revenue | 2024-05-01 → 2024-10-31 | ¥3.6bn |
| —segment total | revenue external | 2024-05-01 → 2024-10-31 | ¥3.6bn |
| —segment total | revenue intersegment | 2024-05-01 → 2024-10-31 | ¥9m |
| —segment total | segment profit | 2024-05-01 → 2024-10-31 | ¥260m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-05-01 → 2024-10-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-05-01 → 2024-10-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-05-01 → 2024-10-31 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-05-01 → 2024-10-31 | ¥241m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 525
| Item | Context | Value | Unit |
|---|---|---|---|
| Net defined benefit liability | Prior1YearInstant | 50290000 | JPY |
| Net defined benefit liability | InterimInstant | 52894000 | JPY |
| Other ncl | Prior1YearInstant | 7117000 | JPY |
| Other ncl | InterimInstant | 4488000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 103872000 | JPY |
| Noncurrent liabilities | InterimInstant | 96162000 | JPY |
| Liabilities | Prior1YearInstant | 1683893000 | JPY |
| Liabilities | InterimInstant | 1594733000 | JPY |
| Capital stock | Prior1YearInstant | 887645000 | JPY |
| Capital stock | InterimInstant | 887645000 | JPY |
| Capital surplus | Prior1YearInstant | 1100341000 | JPY |
| Capital surplus | InterimInstant | 1100341000 | JPY |
| Retained earnings | Prior1YearInstant | 4874147000 | JPY |
| Retained earnings | InterimInstant | 4742469000 | JPY |
| Treasury stock | Prior1YearInstant | -225040000 | JPY |
| Treasury stock | InterimInstant | -216432000 | JPY |
| Shareholders equity | Prior1YearInstant | 6637092000 | JPY |
| Shareholders equity | InterimInstant | 6514024000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 35747000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 52639000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 95479000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 87675000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 131226000 | JPY |
| Valuation and translation adjustments | InterimInstant | 140314000 | JPY |
| Net assets | Prior1YearInstant | 6768319000 | JPY |
| Net assets | InterimInstant | 6654338000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 8452213000 | JPY |
| Liabilities and net assets | InterimInstant | 8249072000 | JPY |
| Net sales | Prior1InterimDuration | 3720312000 | JPY |
| Net sales | InterimDuration | 3777315000 | JPY |
| Cost of sales | Prior1InterimDuration | 2932829000 | JPY |
| Cost of sales | InterimDuration | 3002037000 | JPY |
| Gross profit | Prior1InterimDuration | 787483000 | JPY |
| Gross profit | InterimDuration | 775278000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 730747000 | JPY |
| Selling general and administrative expenses | InterimDuration | 763088000 | JPY |
| Operating income | Prior1InterimDuration | 56736000 | JPY |
| Operating income | InterimDuration | 12190000 | JPY |
| Interest income noi | Prior1InterimDuration | 390000 | JPY |
| Interest income noi | InterimDuration | 1681000 | JPY |
| Dividends income noi | Prior1InterimDuration | 2956000 | JPY |
| Dividends income noi | InterimDuration | 3387000 | JPY |
| Foreign exchange gains noi | Prior1InterimDuration | － | JPY |
| Foreign exchange gains noi | InterimDuration | 1134000 | JPY |
| Fiduciary obligation fee noi | Prior1InterimDuration | 3399000 | JPY |
| Fiduciary obligation fee noi | InterimDuration | 2599000 | JPY |
| Insurance premiums refunded cancellation noi | Prior1InterimDuration | 2409000 | JPY |
| Insurance premiums refunded cancellation noi | InterimDuration | － | JPY |
| Gain on sales of goods noi | Prior1InterimDuration | 3283000 | JPY |
| Gain on sales of goods noi | InterimDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |